# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-001600
Filing Date
2025-03-31
Accepted
2025-03-31 14:06:25
Documents
69
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 1824137
2 |  | ex19-1.htm | EX-19.1 | 107377
3 |  | ex23-1.htm | EX-23.1 | 4547
4 |  | ex31-1.htm | EX-31.1 | 12157
5 |  | ex31-2.htm | EX-31.2 | 11812
6 |  | ex32-1.htm | EX-32.1 | 10095
7 |  | ex23-1_001.jpg | GRAPHIC | 21859
8 |  | ex23-1_002.jpg | GRAPHIC | 138643
9 |  | form10-k_001.jpg | GRAPHIC | 32352
10 |  | form10-k_002.jpg | GRAPHIC | 16929
11 |  | form10-k_003.jpg | GRAPHIC | 28005
12 |  | form10-k_004.jpg | GRAPHIC | 23792
| Complete submission text file | 0001641172-25-001600.txt |  | 6758648

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL SCHEMA FILE | ptix-20241231.xsd | EX-101.SCH | 37476
14 | XBRL CALCULATION FILE | ptix-20241231_cal.xml | EX-101.CAL | 49617
15 | XBRL DEFINITION FILE | ptix-20241231_def.xml | EX-101.DEF | 198868
16 | XBRL LABEL FILE | ptix-20241231_lab.xml | EX-101.LAB | 396235
17 | XBRL PRESENTATION FILE | ptix-20241231_pre.xml | EX-101.PRE | 308887
72 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 678363

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12555 | Film No.: 25791549
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)